Retrospective Continuous-Time Blood Glucose Estimation in Free Living Conditions with a Non-Invasive Multisensor Device.
Giada AcciaroliMattia ZanonAndrea FacchinettiAndreas CaduffGiovanni SparacinoPublished in: Sensors (Basel, Switzerland) (2019)
Even if still at an early stage of development, non-invasive continuous glucose monitoring (NI-CGM) sensors represent a promising technology for optimizing diabetes therapy. Recent studies showed that the Multisensor provides useful information about glucose dynamics with a mean absolute relative difference (MARD) of 35.4% in a fully prospective setting. Here we propose a method that, exploiting the same Multisensor measurements, but in a retrospective setting, achieves a much better accuracy. Data acquired by the Multisensor during a long-term study are retrospectively processed following a two-step procedure. First, the raw data are transformed to a blood glucose (BG) estimate by a multiple linear regression model. Then, an enhancing module is applied in cascade to the regression model to improve the accuracy of the glucose estimation by retrofitting available BG references through a time-varying linear model. MARD between the retrospectively reconstructed BG time-series and reference values is 20%. Here, 94% of values fall in zone A or B of the Clarke Error Grid. The proposed algorithm achieved a level of accuracy that could make this device a potential complementary tool for diabetes management and also for guiding prediabetic or nondiabetic users through life-style changes.
Keyphrases
- blood glucose
- glycemic control
- type diabetes
- early stage
- cardiovascular disease
- electronic health record
- machine learning
- big data
- weight loss
- healthcare
- deep learning
- stem cells
- squamous cell carcinoma
- minimally invasive
- insulin resistance
- metabolic syndrome
- radiation therapy
- bone marrow
- low cost
- health information
- lymph node
- neoadjuvant chemotherapy
- data analysis